These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2867302)

  • 1. Which antibiotic for bacteria with inducible class I beta-lactamase?
    Weinbren MJ; Perinpanayagam RM
    Lancet; 1986 Jan; 1(8472):102. PubMed ID: 2867302
    [No Abstract]   [Full Text] [Related]  

  • 2. Which antibiotic for bacteria with inducible class I beta-lactamase?
    Shannon KP; King A; Eykyn SJ
    Lancet; 1985 Nov; 2(8462):1016. PubMed ID: 2865492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined antibiotic therapy in the complex treatment of patients with acute destructive pancreatitis].
    Taranenko LD; Belonenko GA; Varenko IuS
    Klin Khir (1962); 1991; (11):63. PubMed ID: 1687224
    [No Abstract]   [Full Text] [Related]  

  • 4. Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.
    Watkins RR; Deresinski S
    Expert Rev Anti Infect Ther; 2017 Oct; 15(10):893-895. PubMed ID: 28914107
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital.
    Jamal W; Rotimi VO; Khodakhast F; Saleem R; Pazhoor A; Al Hashim G
    Med Princ Pract; 2005; 14(5):325-31. PubMed ID: 16103698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam.
    Peterson LR
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():181-4. PubMed ID: 18154544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
    MacGowan A
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():166-8. PubMed ID: 18154541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
    Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin in combination with rifampin and imipenem for treating a blaVIM-1 metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient.
    Tascini C; Urbani L; Biancofiore G; Rossolini GM; Leonildi A; Gemignani G; Bindi ML; Mugnaioli C; Filipponi F; Menichetti F
    Minerva Anestesiol; 2008; 74(1-2):47-9. PubMed ID: 18059255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactamase detection in nosocomial bacterial pathogens in Lagos, Nigeria.
    Kesah CN; Odugbemi TO
    Niger Postgrad Med J; 2002 Dec; 9(4):210-3. PubMed ID: 12690681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of urinary tract infections caused by extended spectrum β-lactamase-producing Enterobacteriaceae in children.
    Tratselas A; Iosifidis E; Ioannidou M; Saoulidis S; Kollios K; Antachopoulos C; Sofianou D; Roilides EJ
    Pediatr Infect Dis J; 2011 Aug; 30(8):707-10. PubMed ID: 21248655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?
    Perez F; El Chakhtoura NG; Papp-Wallace KM; Wilson BM; Bonomo RA
    Expert Opin Pharmacother; 2016; 17(6):761-81. PubMed ID: 26799840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Extended Spectrum β-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas from Patients of Khyber Pakhtunkhwa, Pakistan.
    Ahmad M; Hassan M; Khalid A; Tariq I; Asad MH; Samad A; Mahmood Q; Murtaza G
    Biomed Res Int; 2016; 2016():6068429. PubMed ID: 27366750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
    Falagas ME; Karageorgopoulos DE; Nordmann P
    Future Microbiol; 2011 Jun; 6(6):653-66. PubMed ID: 21707312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metallo-beta-lactamase producing bacteria].
    Takemura H
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():453-6. PubMed ID: 17455661
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
    Tamma PD; Girdwood SC; Gopaul R; Tekle T; Roberts AA; Harris AD; Cosgrove SE; Carroll KC
    Clin Infect Dis; 2013 Sep; 57(6):781-8. PubMed ID: 23759352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.
    Araoka H; Baba M; Takagi S; Matsuno N; Ishiwata K; Nakano N; Tsuji M; Yamamoto H; Seo S; Asano-Mori Y; Uchida N; Masuoka K; Wake A; Taniguchi S; Yoneyama A
    Scand J Infect Dis; 2010 Mar; 42(3):231-3. PubMed ID: 20001223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 19. [Extended-spectrum beta-lactamase producing-enterobacteriaceae].
    Mariani-Kurkdjian P; Doit C; Bingen E
    Arch Pediatr; 2012 Nov; 19 Suppl 3():S93-6. PubMed ID: 23178141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa].
    Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C
    Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.